HUMORAL AND CELLULAR IMMUNE RESPONSES AGAINST SHIV INFECTION
针对 SHIV 感染的体液和细胞免疫反应
基本信息
- 批准号:8172683
- 负责人:
- 金额:$ 6.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdultAnimalsAntibody FormationBiomedical ResearchCD4 Positive T LymphocytesCD8B1 geneCellsCessation of lifeCollaborationsComputer Retrieval of Information on Scientific Projects DatabaseComputer SimulationCytotoxic T-LymphocytesDevelopmentDiseaseFundingGenerationsGrantHIVHIV-1HumanImmuneImmune responseImmunityInfectionInstitutionLaboratoriesLearningMonkeysOrganPatientsPersonsPharmaceutical PreparationsPhasePlasmaProductionProgressive DiseaseResearchResearch InstituteResearch PersonnelResourcesSIVScientistSourceT-Cell DepletionT-LymphocyteTestingTimeUnited States National Institutes of HealthVaccinesViralVirusVirus DiseasesVirus Replicationfightinglymph nodesneutralizing antibodyresponsetheories
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The Acquired Immunodeficiency Syndrome (AIDS) is caused by a virus called the human immunodeficiency virus (HIV) and has resulted over the last 25 years in millions of death worldwide. The early phase of the infection is crucial in the eventual progress toward AIDS. Soon after entering the body, HIV rapidly spreads to the lymph nodes and others organs where it makes many millions of copies of itself. If the virus could be well contained at the beginning, the infected person would develop AIDS only after many years while a person with rapid expansion of the virus in the first days of infection would develop AIDS much sooner. Despite recent progress in our understanding of Human Immunodeficiency Virus disease the actual mechanisms responsible for controlling the replication of the virus in the infected host remain poorly understood.
CD4+ T cell depletion and the progression of HIV-1-related diseases are progressive in adults infected with HlV-L Some of the reasons why adults are able to longer survive over the time of the infection may be due to differences in the host immune control of virus replication such as the stronger presence of CD8 cytotoxic T lymphocytes (or "killer T lymphocytes) and a better neutralizing antibody response, that have been shown to inhibit HIV replication.
Animal studies can help address critical questions that cannot be answered in human studies, in computer models or laboratory dishes. Most animal AIDS research is conducted with monkeys. Some monkeys are infected with SIV, a virus very similar to HIV that causes an AIDS-like disease. The similarities between SIV and HIV allow scientists to test theories, vaccines, and medications that could otherwise never by tested.
In collaboration with Dr. Leonidas Stamatatos from the Seattle Biomedical Research Institute (SBRI, Seattle WA), we will investigate the development of immunity to the virus longitudinally to determine how the body learns to fight SlV. We will particularly investigate the generation of virus-specific neutralizing antibodies and cellular immune responses such as the CD8 cytotoxic T lymphocyte responses in an effort to correlate these responses with control of virus concentration in the plasma. With this study, we are expecting to see an increased production of anti-virus neutralizing antibody responses and strong anti-viral cell responses that will mimic the immune responses observed during HIV infection in patient.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
获得的免疫缺陷综合征(AIDS)是由一种称为人类免疫缺陷病毒(HIV)的病毒引起的,在过去的25年中,全世界数百万死亡导致。感染的早期阶段对于最终朝着艾滋病的进展至关重要。进入身体后不久,艾滋病毒迅速传播到淋巴结和其他机器人,在那里它制作了数百万本身。如果一开始就可以很好地控制该病毒,那么感染者才会在多年后才发展艾滋病,而感染最初几天病毒迅速扩张的人会早日发展艾滋病。尽管我们对人类免疫缺陷病毒疾病的理解最近取得了进展,但负责控制感染宿主中该病毒复制的实际机制仍然很众所周知。
在感染HLV-L的成年人中,CD4+ T细胞的耗竭和与HIV-1相关疾病的进展是逐渐逐渐的抗体反应已显示可抑制HIV复制。
动物研究可以帮助解决人类研究,计算机模型或实验室菜肴中无法回答的关键问题。大多数动物艾滋病研究是通过猴子进行的。一些猴子感染了SIV,这种病毒与引起类似艾滋病疾病的HIV非常相似。 SIV和HIV之间的相似性使科学家可以测试否则可以通过测试的理论,疫苗和药物。
与西雅图生物医学研究所(SBRI,西雅图)的Leonidas Stamatatos博士合作,我们将纵向调查对病毒的免疫力的发展,以确定身体如何学会与SLV作战。我们将特别研究病毒特异性中和抗体和细胞免疫反应的产生,例如CD8细胞毒性T淋巴细胞反应,以努力将这些反应与血浆中病毒浓度的控制相关。通过这项研究,我们预计抗病毒中和抗体反应的产生和强烈的抗病毒细胞反应会增加,这些反应将模仿患者HIV感染期间观察到的免疫反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marie-Claire Elisabeth Gauduin其他文献
Marie-Claire Elisabeth Gauduin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marie-Claire Elisabeth Gauduin', 18)}}的其他基金
Durable HIV Vaccine Targeting Mucosal Epithelium
针对粘膜上皮的耐用 HIV 疫苗
- 批准号:
10548066 - 财政年份:2022
- 资助金额:
$ 6.34万 - 项目类别:
Durable HIV Vaccine Targeting Mucosal Epithelium
针对粘膜上皮的耐用 HIV 疫苗
- 批准号:
10675701 - 财政年份:2022
- 资助金额:
$ 6.34万 - 项目类别:
A Neonatal Monkey Model of Tuberculosis Vaccination
新生猴结核病疫苗接种模型
- 批准号:
9901954 - 财政年份:2019
- 资助金额:
$ 6.34万 - 项目类别:
A Neonatal Monkey Model for Tuberculosis Vaccination
结核病疫苗接种的新生猴模型
- 批准号:
9201694 - 财政年份:2017
- 资助金额:
$ 6.34万 - 项目类别:
Recombinant Papillomavirus-based HIV Vaccine Targeting Genital Mucosa
针对生殖器粘膜的基于重组乳头瘤病毒的 HIV 疫苗
- 批准号:
8993591 - 财政年份:2015
- 资助金额:
$ 6.34万 - 项目类别:
Trans-complementing papillioma virus for AIDS vaccine
用于艾滋病疫苗的反式互补乳头状瘤病毒
- 批准号:
9011505 - 财政年份:2015
- 资助金额:
$ 6.34万 - 项目类别:
EFFICACY OF A DNA/MVA VACCINE TO PROTECT AGAINST REPEATED VAGINAL SIV CHALLENGE
DNA/MVA 疫苗预防反复阴道 SIV 攻击的功效
- 批准号:
8357926 - 财政年份:2011
- 资助金额:
$ 6.34万 - 项目类别:
EPITHELIAL CELLS AS MUCOSAL ADJUVANT FOR LIFE LONG IMMUNITY
上皮细胞作为终身免疫的粘膜佐剂
- 批准号:
8357687 - 财政年份:2011
- 资助金额:
$ 6.34万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 6.34万 - 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
- 批准号:
10762280 - 财政年份:2023
- 资助金额:
$ 6.34万 - 项目类别: